Delcath Systems Stock

Delcath Systems PEG

The PEG Ratio (Price/Earnings-to-Growth) of Delcath Systems (DCTH) as of Jul 23, 2026 is -0.20. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -0.26 — a change of -24.20% (higher).

PEG

-0.20

YoY

-24.20%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Delcath Systems is 2026 -0.20 . PEG Ratio (Price/Earnings-to-Growth) of Delcath Systems was 2025 -0.26 . It decreases by -24.20% higher compared to the previous year.
Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

PEG Ratio (Price/Earnings-to-Growth) of Delcath Systems is -0.20 in 2026.

Access this data via the Eulerpool API

Valuation — Delcath Systems

All Key Metrics — Delcath Systems